In the News

Dr. Daniel W. Foster, Longtime UT Southwestern Internal Medicine Chairman: 1930-2018


Dr. Daniel W. Foster, a world-renowned diabetes expert, inspiring medical school instructor, and nationally recognized Chairman of UT Southwestern Medical Center’s Department of Internal Medicine for 16 years, died Jan. 18.

UT Southwestern Perspectives from ObesityWeek


UT Southwestern’s Dr. Jeffrey Zigman, Professor of Internal Medicine and Psychiatry, and Dr. Jaime Almandoz, Assistant Professor of Internal Medicine, attended ObesityWeek 2017 and shared the following insights about new research in this field.

Dr. Rhodes part of multicenter study of end-of-life care in African Americans


UT Southwestern has been selected as one of the sites in a five-year, multicenter study that aims to reduce disparities in the quality of end-of-life care often experienced by elderly African-Americans.

Dr. Ramona Rhodes, Associate Professor of Internal Medicine, serves as Principal Investigator of the local component in the $5.82 million Duke University-based investigation supported by the Patient-Centered Outcomes Research Institute (PCORI). 

Dr. Levine's prescription for life


Exercise can reverse damage to sedentary, aging hearts and help prevent risk of future heart failure – if it’s enough exercise, and if it’s begun in time, according to a new study by cardiologists at UT Southwestern and Texas Health Resources. “Based on a series of studies performed by our team over the past 5 years, this ‘dose’ of exercise has become my prescription for life,” said senior author Dr. Benjamin Levine, Director of the Institute and Professor of Internal Medicine at UT Southwestern. 

Dr. Scherer discusses link between fat tissue and disease


Body fat can seem mysterious and confounding, but Dr. Philipp E. Scherer aims to unravel those mysteries – especially in regard to fat’s relationship with disease.

Drs. Courtney and Brugarolas publish finding on HIF-2a inhibitors


Metastatic kidney cancer remains largely incurable. Despite a dozen treatments and several immunotherapies, survival rates beyond 5 years remain around 10 percent. A study published in the Journal of Clinical Oncology reports initial findings with a novel drug belonging to a new class of medicines called HIF-2a inhibitors that show promise in treating metastatic kidney cancer.

Dr. Harvey gives advice on seasonal allergies


Allergy specialists like Dr. Shelly Harvey are again readying themselves for mountain cedar, the annual irritant that makes noses run and eyes itch – potentially transforming the merriest of holiday well-wishers into miserable Ebenezer Scrooges.

Dr. Paulk selected for distinguished professorship


Dr. Elizabeth Paulk’s dedication to exceptional palliative care has led to her selection as the inaugural holder of the Distinguished Professorship in Palliative Care, in Honor of Steven Leach, M.D“I am deeply moved by this honor,” said Dr. Paulk, Director of UT Southwestern’s Palliative Care Fellowship Program and Associate Director of the Internal Medicine Residency Program.

Dr. Shiloh uses magnetic field to treat infections on artificial joints


A short exposure to an alternating magnetic field might someday replace multiple surgeries and weeks of IV antibiotics as treatment for stubborn infections on artificial joints, new research suggests. Technology developed by Dr. Rajiv Chopra and Dr. David Greenberg uses this method to heat the surface of prosthetic metal joints and destroy bacterial biofilms. Their work appears in Scientific Reports.

Doctors find cancer survivors excluded from Clinical Trials


A quarter of newly diagnosed cancer patients 65 or older are survivors who had a prior cancer are often prevented from participating in clinical trials, researchers from UT Southwestern’s Simmons Cancer Center have found. This study builds on prior work on lung cancer done by Dr. Sandi Pruitt and Dr. David Gerber.